Hu X, Yang Y, Feng G, Zhou X, Tang M, Yan H
F S Rep. 2024; 5(3):272-278.
PMID: 39381649
PMC: 11456660.
DOI: 10.1016/j.xfre.2024.07.002.
Kwiatkowska K, Anticoli S, Salvioli S, Calzari L, Gentilini D, Albano C
Vaccines (Basel). 2024; 12(8).
PMID: 39204006
PMC: 11360008.
DOI: 10.3390/vaccines12080880.
Naqid I, Mosa A, Ibrahim S, Ibrahim N, Hussein N
PLoS One. 2023; 18(11):e0293822.
PMID: 37930973
PMC: 10627443.
DOI: 10.1371/journal.pone.0293822.
Ballester M, Jalan R, Mehta G
JHEP Rep. 2023; :100776.
PMID: 37360567
PMC: 10241163.
DOI: 10.1016/j.jhepr.2023.100776.
Lu J, Zhang X, Xu H, Li Z
Front Pediatr. 2022; 10:888686.
PMID: 36210931
PMC: 9538941.
DOI: 10.3389/fped.2022.888686.
Efficacy of Hepatitis B Virus Vaccines HBVaxpro40© and Fendrix© in Patients with Chronic Liver Disease in Clinical Practice.
Horta D, Forne M, Agusti A, Raga A, Martin-Cardona A, Hernandez-Soto J
Vaccines (Basel). 2022; 10(8).
PMID: 36016211
PMC: 9416157.
DOI: 10.3390/vaccines10081323.
Plasma Cytokines and Birth Weight as Biomarkers of Vaccine-Induced Humoral Responses in Piglets.
Lipsit S, Facciuolo A, Scruten E, Griebel P, Napper S
Front Vet Sci. 2022; 9:922992.
PMID: 35903142
PMC: 9325413.
DOI: 10.3389/fvets.2022.922992.
[Hepatitis B in indigenous people in Latin America: a literature reviewHepatite B em indígenas na América Latina: revisão da literatura].
Castro-Arroyave D, Martinez-Gallego J, Montoya-Guzman M, Silva G, Rojas Arbelaez C
Rev Panam Salud Publica. 2022; 46:e22.
PMID: 35350451
PMC: 8942283.
DOI: 10.26633/RPSP.2022.22.
Current Progress in the Development of Hepatitis B Virus Capsid Assembly Modulators: Chemical Structure, Mode-of-Action and Efficacy.
Kim H, Ko C, Lee J, Kim M
Molecules. 2021; 26(24).
PMID: 34946502
PMC: 8705634.
DOI: 10.3390/molecules26247420.
A systematic review and meta-analysis of the prevalence of hepatitis B virus infection among pregnant women in Nigeria.
Olakunde B, Adeyinka D, Olakunde O, Uthman O, Bada F, Nartey Y
PLoS One. 2021; 16(10):e0259218.
PMID: 34714888
PMC: 8555786.
DOI: 10.1371/journal.pone.0259218.
Protein-based antigen presentation platforms for nanoparticle vaccines.
Nguyen B, Tolia N
NPJ Vaccines. 2021; 6(1):70.
PMID: 33986287
PMC: 8119681.
DOI: 10.1038/s41541-021-00330-7.
Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity.
Awad G, Roch T, Stervbo U, Kaliszczyk S, Stittrich A, Horstrup J
Mol Ther Methods Clin Dev. 2021; 21:288-298.
PMID: 33898628
PMC: 8050104.
DOI: 10.1016/j.omtm.2021.03.012.
Vaccination against Hepatitis B: A Scoping Review.
Mohanty P, Jena P, Patnaik L
Asian Pac J Cancer Prev. 2020; 21(12):3453-3459.
PMID: 33369439
PMC: 8046310.
DOI: 10.31557/APJCP.2020.21.12.3453.
A simple clinical score to identify likely hepatitis B vaccination non-responders - data from a retrospective single center study.
Meier M, Berger C
BMC Infect Dis. 2020; 20(1):891.
PMID: 33238923
PMC: 7690196.
DOI: 10.1186/s12879-020-05634-y.
Infection prophylaxis and management of viral infection.
S Clausen E, Zaffiri L
Ann Transl Med. 2020; 8(6):415.
PMID: 32355859
PMC: 7186616.
DOI: 10.21037/atm.2019.11.85.
Hepatitis B vaccine development and implementation.
Zhao H, Zhou X, Zhou Y
Hum Vaccin Immunother. 2020; 16(7):1533-1544.
PMID: 32186974
PMC: 7482909.
DOI: 10.1080/21645515.2020.1732166.
Advantages and Prospects of Tag/Catcher Mediated Antigen Display on Capsid-Like Particle-Based Vaccines.
Aves K, Goksoyr L, Sander A
Viruses. 2020; 12(2).
PMID: 32041299
PMC: 7077247.
DOI: 10.3390/v12020185.
Comparison of hepatitis B vaccine efficacy in Japanese students: a retrospective study.
Ogawa M, Akine D, Sasahara T
Environ Health Prev Med. 2019; 24(1):80.
PMID: 31878867
PMC: 6933897.
DOI: 10.1186/s12199-019-0837-1.
Study on Status and Willingness towards Hepatitis B Vaccination among Migrant Workers in Chongqing, China: A Cross-Sectional Study.
Xiang H, Tang X, Xiao M, Gan L, Chu K, Li S
Int J Environ Res Public Health. 2019; 16(20).
PMID: 31652590
PMC: 6843977.
DOI: 10.3390/ijerph16204046.
Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations.
Rondaan C, Furer V, Heijstek M, Agmon-Levin N, Bijl M, Breedveld F
RMD Open. 2019; 5(2):e001035.
PMID: 31565247
PMC: 6744079.
DOI: 10.1136/rmdopen-2019-001035.
